Bristol-Meyer Squibb is Stealing the Pearl Necklace!!!Monoclonal Antibodies FDA approval over the last 10 years..Melanoma..Jim Breitfeller

Monoclonal antibodies used to treat cancer MAb Name
Trade Name
Used to Treat:
Approved in:

Rituximab
Rituxan
Non-Hodgkin lymphoma
1997

Trastuzumab
Herceptin
Breast cancer
1998

Gemtuzumab ozogamicin*
Mylotarg
Acute myelogenous leukemia (AML)
2000

Alemtuzumab
Campath
Chronic lymphocytic leukemia (CLL)
2001

Ibritumomab tiuxetan*
Zevalin
Non-Hodgkin lymphoma
2002

Tositumomab*
Bexxar
Non-Hodgkin lymphoma
2003

Cetuximab
Erbitux
Colorectal cancer
Head & neck cancers
2004
2006

Bevacizumab
Avastin
Colorectal cancer
Non-small cell lung cancer
Advanced breast cancer
2004
2006
2008

Panitumumab
Vectibix
Colorectal cancer
2006



*conjugated monoclonal antibodies

Two types of monoclonal antibodies are used in cancer treatments:

Naked monoclonal antibodies are those without any drug or radioactive material attached to them.
Conjugated monoclonal antibodies are those joined to a chemotherapy drug, radioactive particle, or a toxin (a substance that poisons cells).

http://www.cancer.org/docroot/ETO/conten...

Think what Our 40+ Antibodies in the pipeline of the Medarex Company are worth.

We have been sold out by Pien and Company!!!!

Bristol-Meyer Squibb is stealing the Pear Necklace from the Medarex Shareholders.

The Boards of Both Companies should be Investigated along with the CEO's

Take Care,

Jimmy B